SANUWAVE Health, Inc. Common Stock (SNWV) - Total Liabilities
Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has total liabilities worth $35.26 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SANUWAVE Health, Inc. Common Stock - Total Liabilities Trend (2006–2025)
This chart illustrates how SANUWAVE Health, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See SNWV working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
SANUWAVE Health, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Unifi Inc
NYSE:UFI
|
USA | $160.50 Million |
|
Pembangunan Perumahan PT
JK:PTPP
|
Indonesia | Rp40.22 Trillion |
|
BARK, Inc.
NYSE:BARK
|
USA | $107.42 Million |
|
XXL ASA
OL:XXL
|
Norway | Nkr5.35 Billion |
|
Tridomain Performance Materials PT
JK:TDPM
|
Indonesia | Rp128.03 Million |
|
Hainan Poly Pharm Co Ltd
SHE:300630
|
China | CN¥3.45 Billion |
|
US Masters Residential Property Fund
AU:URF
|
Australia | AU$124.56 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down SANUWAVE Health, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SANUWAVE Health, Inc. Common Stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 19.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.95 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SANUWAVE Health, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SANUWAVE Health, Inc. Common Stock (2006–2025)
The table below shows the annual total liabilities of SANUWAVE Health, Inc. Common Stock from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $35.72 Million | -16.60% |
| 2024-12-31 | $42.84 Million | -34.70% |
| 2023-12-31 | $65.59 Million | +7.74% |
| 2022-12-31 | $60.88 Million | +5.74% |
| 2021-12-31 | $57.58 Million | +56.69% |
| 2020-12-31 | $36.75 Million | +173.30% |
| 2019-12-31 | $13.45 Million | -18.68% |
| 2018-12-31 | $16.53 Million | +48.16% |
| 2017-12-31 | $11.16 Million | +40.97% |
| 2016-12-31 | $7.92 Million | +15.80% |
| 2015-12-31 | $6.84 Million | +9.95% |
| 2014-12-31 | $6.22 Million | -19.42% |
| 2013-12-31 | $7.72 Million | -7.81% |
| 2012-12-31 | $8.37 Million | +8.66% |
| 2011-12-31 | $7.70 Million | -43.13% |
| 2010-12-31 | $13.55 Million | +15.27% |
| 2009-12-31 | $11.75 Million | +15322.39% |
| 2008-12-31 | $76.20K | +47.75% |
| 2007-12-31 | $51.57K | +25.93% |
| 2006-12-31 | $40.95K | -- |
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more